全事業営業利益、新型感染症対応による損失
- 【期間】
| 年度 | 全事業営業利益 | 新型感染症対応による損失 |
|---|
| 2009/02 | 266億 | | - | |
| 2009/11 | 138億 | -48.2% | - | |
| 2010/02 | 206億 | +49.2% | - | |
| 2010/05 | 41.2億 | -79.9% | - | |
| 2010/08 | 85.1億 | +106.3% | - | |
| 2010/11 | 135億 | +58.7% | - | |
| 2011/02 | 207億 | +53.4% | - | |
| 2011/05 | 44.9億 | -78.3% | - | |
| 2011/08 | 102億 | +127.7% | - | |
| 2011/11 | 167億 | +63.2% | - | |
| 2012/02 | 243億 | +45.4% | - | |
| 2012/05 | 61.8億 | -74.5% | - | |
| 2012/08 | 129億 | +109.2% | - | |
| 2012/11 | 206億 | +59% | - | |
| 2013/03 | 331億 | +60.9% | - | |
| 2013/09 | 4.31億 | -98.7% | - | |
| 2014/03 | 14.2億 | +229.7% | - | |
| 2014/09 | 79.2億 | +457.3% | - | |
| 2015/03 | 126億 | +58.7% | - | |
| 2015/09 | 58.4億 | -53.5% | - | |
| 2016/03 | 120億 | +105.9% | - | |
| 2016/09 | 79億 | -34.3% | - | |
| 2017/03 | 159億 | +100.7% | - | |
| 2017/09 | 70.3億 | -55.7% | - | |
| 2018/03 | 136億 | +94% | - | |
| 2018/06 | 141億 | +3.5% | - | |
| 2018/09 | 81.6億 | -42.1% | - | |
| 2018/12 | 521億 | +538.6% | - | |
| 2019/03 | 146億 | -72.1% | - | |
| 2019/06 | 136億 | -6.6% | - | |
| 2019/09 | 249億 | +83.5% | - | |
| 2019/12 | 431億 | +73% | - | |
| 2020/02 | 651億 | +50.8% | - | |
| 2020/05 | -8.63億 | 赤転 | 161百万 | |
| 2020/08 | 77.7億 | 黒転 | 361百万 | +124.2% |
| 2020/11 | 249億 | +220% | 409百万 | +13.3% |
| 2021/02 | 407億 | +63.6% | 436百万 | +6.6% |
| 2021/05 | 207億 | -49.1% | 12百万 | -97.2% |
| 2021/08 | 332億 | +60.5% | 17百万 | +41.7% |
| 2021/11 | 442億 | +33.1% | 37百万 | +117.6% |
| 2022/02 | 589億 | +33.1% | 48百万 | +29.7% |
| 2022/05 | 153億 | -74% | 8百万 | -83.3% |
| 2022/08 | 319億 | +108.4% | 14百万 | +75% |
| 2022/11 | 416億 | +30.5% | 19百万 | +35.7% |
| 2023/02 | 589億 | +41.6% | 24百万 | +26.3% |
| 2023/05 | 91.9億 | -84.4% | - | |
| 2023/08 | 203億 | +120.8% | - | |
| 2023/11 | 261億 | +28.7% | - | |
| 2024/02 | 501億 | +91.8% | - | |
| 2024/05 | 152億 | -69.6% | - | |
